125 related articles for article (PubMed ID: 36436615)
1. Left Anterior Descending Coronary Artery Radiation Dose Association With All-Cause Mortality in NRG Oncology Trial RTOG 0617.
McKenzie E; Zhang S; Zakariaee R; Guthier CV; Hakimian B; Mirhadi A; Kamrava M; Padda SK; Lewis JH; Nikolova A; Mak RH; Atkins KM
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1138-1143. PubMed ID: 36436615
[TBL] [Abstract][Full Text] [Related]
2. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.
Atkins KM; Chaunzwa TL; Lamba N; Bitterman DS; Rawal B; Bredfeldt J; Williams CL; Kozono DE; Baldini EH; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
JAMA Oncol; 2021 Feb; 7(2):206-219. PubMed ID: 33331883
[TBL] [Abstract][Full Text] [Related]
3. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy.
Atkins KM; Bitterman DS; Chaunzwa TL; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1473-1479. PubMed ID: 33713743
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium.
Dess RT; Sun Y; Muenz DG; Paximadis PA; Dominello MM; Grills IS; Kestin LL; Movsas B; Masi KJ; Matuszak MM; Radawski JD; Moran JM; Pierce LJ; Hayman JA; Schipper MJ; Jolly S;
Pract Radiat Oncol; 2020; 10(1):e27-e36. PubMed ID: 31382026
[TBL] [Abstract][Full Text] [Related]
5. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
6. Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation.
Yegya-Raman N; Ho Lee S; Friedes C; Wang X; Iocolano M; Kegelman TP; Duan L; Li B; Berlin E; Kim KN; Doucette A; Denduluri S; Levin WP; Cengel KA; Cohen RB; Langer CJ; Kevin Teo BK; Zou W; O'Quinn RP; Deasy JO; Bradley JD; Sun L; Ky B; Xiao Y; Feigenberg SJ
Radiother Oncol; 2024 Jan; 190():110005. PubMed ID: 37972736
[TBL] [Abstract][Full Text] [Related]
7. Dose to the Left Anterior Descending Artery Correlates With Cardiac Events After Irradiation for Breast Cancer.
Zureick AH; Grzywacz VP; Almahariq MF; Silverman BR; Vayntraub A; Chen PY; Gustafson GS; Jawad MS; Dilworth JT
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):130-139. PubMed ID: 35483540
[TBL] [Abstract][Full Text] [Related]
8. Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer.
Atkins KM; Bitterman DS; Chaunzwa TL; Williams CL; Rahman R; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Pract Radiat Oncol; 2021; 11(5):e459-e467. PubMed ID: 33476841
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
10. Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
Lee SH; Geng H; Arnold J; Caruana R; Fan Y; Rosen MA; Apte AP; Deasy JO; Bradley JD; Xiao Y
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1270-1286. PubMed ID: 37343707
[TBL] [Abstract][Full Text] [Related]
11. Left anterior descending artery avoidance in patients receiving breast irradiation.
Vayntraub A; Quinn TJ; Thompson AB; Chen PY; Gustafson GS; Jawad MS; Dilworth JT
Med Dosim; 2021 Spring; 46(1):57-64. PubMed ID: 32878728
[TBL] [Abstract][Full Text] [Related]
12. Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy.
Sonnick MA; Oro F; Yan B; Desai A; Wu AJ; Shi W; Zhang Z; Gelblum DY; Paik PK; Yorke ED; Rosenzweig KE; Chaft JE; Rimner A
Clin Lung Cancer; 2018 Jan; 19(1):e131-e140. PubMed ID: 28756051
[TBL] [Abstract][Full Text] [Related]
13. Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL).
Tjong MC; Bitterman DS; Brantley K; Nohria A; Hoffmann U; Atkins KM; Mak RH
Radiother Oncol; 2022 Apr; 169():105-113. PubMed ID: 35182687
[TBL] [Abstract][Full Text] [Related]
14. The Importance of Radiation Dose to the Atherosclerotic Plaque in the Left Anterior Descending Coronary Artery for Radiation-Induced Cardiac Toxicity of Breast Cancer Patients?
van den Bogaard VAB; Spoor DS; van der Schaaf A; van Dijk LV; Schuit E; Sijtsema NM; Langendijk JA; Maduro JH; Crijns APG
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1350-1359. PubMed ID: 33713741
[TBL] [Abstract][Full Text] [Related]
15. Assessing radiation exposure of the left anterior descending artery, heart and lung in patients with left breast cancer: A dosimetric comparison between multicatheter accelerated partial breast irradiation and whole breast external beam radiotherapy.
Chan TY; Tan PW; Tan CW; Tang JI
Radiother Oncol; 2015 Dec; 117(3):459-66. PubMed ID: 26328940
[TBL] [Abstract][Full Text] [Related]
16. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM; Moughan J; Purdy J; Bosch W; Bruner DW; Bahary JP; Lau H; Duclos M; Parliament M; Morton G; Hamstra D; Seider M; Lock MI; Patel M; Gay H; Vigneault E; Winter K; Sandler H
JAMA Oncol; 2018 Jun; 4(6):e180039. PubMed ID: 29543933
[TBL] [Abstract][Full Text] [Related]
17. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
[TBL] [Abstract][Full Text] [Related]
18. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group.
Cox JD; Azarnia N; Byhardt RW; Shin KH; Emami B; Perez CA
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):7-12. PubMed ID: 1847128
[TBL] [Abstract][Full Text] [Related]
19. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes.
Krueger EA; Schipper MJ; Koelling T; Marsh RB; Butler JB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1195-203. PubMed ID: 15519792
[TBL] [Abstract][Full Text] [Related]
20. Does mean heart dose sufficiently reflect coronary artery exposure in left-sided breast cancer radiotherapy? : Influence of respiratory gating.
Becker-Schiebe M; Stockhammer M; Hoffmann W; Wetzel F; Franz H
Strahlenther Onkol; 2016 Sep; 192(9):624-31. PubMed ID: 27389036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
